ProShare Advisors’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Buy
48,259
+1,384
+3% +$391K 0.02% 331
2026
Q1
$12.5M Sell
46,875
-7,372
-14% -$2.04M 0.02% 328
2025
Q4
$14.9M Buy
54,247
+6,332
+13% +$1.78M 0.03% 304
2025
Q3
$13.8M Sell
47,915
-998
-2% -$295K 0.03% 308
2025
Q2
$16.2M Buy
48,913
+5,489
+13% +$1.77M 0.03% 292
2025
Q1
$14.3M Sell
43,424
-4,693
-10% -$1.41M 0.03% 293
2024
Q4
$13.3M Buy
48,117
+4,658
+11% +$1.48M 0.03% 290
2024
Q3
$15.1M Sell
43,459
-3,406
-7% -$1.17M 0.04% 279
2024
Q2
$15.5M Buy
46,865
+1,704
+4% +$588K 0.04% 268
2024
Q1
$16.4M Sell
45,161
-1,883
-4% -$620K 0.04% 263
2023
Q4
$14.1M Sell
47,044
-4,096
-8% -$1.2M 0.04% 270
2023
Q3
$14.6M Sell
51,140
-2,417
-5% -$689K 0.05% 264
2023
Q2
$15M Buy
53,557
+69
+0.1% +$18K 0.04% 265
2023
Q1
$13.7M Buy
53,488
+5,552
+12% +$1.62M 0.04% 267
2022
Q4
$15.9M Sell
47,936
-119
-0.2% -$37.7K 0.06% 241
2022
Q3
$13.3M Sell
48,055
-6,714
-12% -$1.89M 0.05% 249
2022
Q2
$14.4M Sell
54,769
-18,348
-25% -$4.73M 0.05% 258
2022
Q1
$17.5M Sell
73,117
-3,483
-5% -$815K 0.04% 279
2021
Q4
$17.6M Buy
76,600
+14,597
+24% +$3.1M 0.03% 280
2021
Q3
$12.4M Buy
62,003
+1,600
+3% +$348K 0.03% 306
2021
Q2
$14.3M Buy
60,403
+9,585
+19% +$2.39M 0.04% 289
2021
Q1
$12.3M Buy
50,818
+1,192
+2% +$266K 0.04% 332
2020
Q4
$10.3M Buy
49,626
+4,214
+9% +$826K 0.04% 296
2020
Q3
$7.69M Buy
45,412
+1,153
+3% +$203K 0.04% 319
2020
Q2
$8.3M Sell
44,259
-9,515
-18% -$1.81M 0.04% 280
2020
Q1
$9.53M Sell
53,774
-32,094
-37% -$6.23M 0.07% 251
2019
Q4
$17.6M Buy
85,868
+10,423
+14% +$1.91M 0.08% 199
2019
Q3
$11.5M Buy
75,445
+1,518
+2% +$247K 0.06% 286
2019
Q2
$11.6M Buy
73,927
+14,292
+24% +$2.24M 0.07% 274
2019
Q1
$9.59M Buy
59,635
+3,538
+6% +$646K 0.06% 293
2018
Q4
$10.7M Buy
56,097
+22,042
+65% +$4.6M 0.07% 206
2018
Q3
$7.09M Sell
34,055
-3,095
-8% -$574K 0.05% 349
2018
Q2
$6.31M Sell
37,150
-2,645
-7% -$458K 0.04% 382
2018
Q1
$6.67M Buy
39,795
+360
+0.9% +$70K 0.04% 380
2017
Q4
$8.01M Buy
39,435
+10,873
+38% +$2.16M 0.06% 316
2017
Q3
$5.34M Buy
28,562
+3,598
+14% +$641K 0.05% 360
2017
Q2
$4.18M Sell
24,964
-966
-4% -$155K 0.04% 387
2017
Q1
$3.8M Buy
25,930
+405
+2% +$59.7K 0.04% 400
2016
Q4
$3.4M Buy
25,525
+4,903
+24% +$642K 0.04% 413
2016
Q3
$2.69M Sell
20,622
-10,487
-34% -$1.37M 0.04% 409
2016
Q2
$3.98M Buy
31,109
+715
+2% +$94.4K 0.05% 289
2016
Q1
$4.17M Sell
30,394
-14,876
-33% -$2.04M 0.06% 271
2015
Q4
$6.62M Buy
45,270
+2,324
+5% +$319K 0.08% 244
2015
Q3
$5.8M Buy
42,946
+1,855
+5% +$269K 0.08% 247
2015
Q2
$6.66M Sell
41,091
-7,270
-15% -$1M 0.09% 219
2015
Q1
$6.26M Sell
48,361
-6,920
-13% -$804K 0.07% 271
2014
Q4
$5.69M Buy
55,281
+8,184
+17% +$807K 0.07% 295
2014
Q3
$4.27M Sell
47,097
-5,628
-11% -$526K 0.06% 330
2014
Q2
$4.85M Sell
52,725
-5,005
-9% -$429K 0.06% 303
2014
Q1
$4.83M Buy
57,730
+5,276
+10% +$434K 0.06% 305
2013
Q4
$4.59M Buy
52,454
+25,053
+91% +$2.05M 0.07% 333
2013
Q3
$2.11M Sell
27,401
-19,351
-41% -$1.51M 0.05% 375
2013
Q2
$3.39M Buy
+46,752
New +$3.15M 0.07% 277

Other funds holding CI

ProShare Advisors's CI Position: Q2 2026 in Review

ProShare Advisors increased its Cigna (CI) stake by 3% in Q2 2026, buying an estimated $391K and bringing the position to 48,259 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #331.

ProShare Advisors first reported a position in CI in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.6M in Q4 2021. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • ProShare Advisors held 48,259 shares of Cigna worth $13.3M as of Q2 2026.
  • ProShare Advisors bought 1,384 Cigna shares in Q2 2026, an estimated $391K.
  • Cigna made up 0.02% of ProShare Advisors's portfolio in Q2 2026, its #331 holding.
  • ProShare Advisors first reported a position in Cigna in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's Cigna position peaked at $17.6M in Q4 2021.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.